期刊文献+

Fibroscan对HBV感染者肝纤维化诊断的临床研究 被引量:17

Clinical study of FibroScan on the diagnosis of liver fibrosis in patients with hepatitis B virus
下载PDF
导出
摘要 目的:探讨FibroScan在HBV感染者肝纤维化诊断中的临床应用价值。方法:随即抽取FibroScan检测的HBV感染者300例,包括急性乙型肝炎患者22例,慢性乙型肝炎161例,乙肝肝硬化117例,分析FibroScan检测值(FS值)与肝功能、HBV载量、血清纤维化指标及超声诊断结果的相关性。结果:FS值与血清学检验指标进行多重线性回归分析,FS值与ALB、TBIL、HA、ALT和LN之间具有显著相关性(P<0.05)。肝硬化组FS值显著高于CHB组和AHB组(P<0.05),但CHB组和AHB组之间比较差异无统计学意义(P>0.05)。FS值与HBV载量高低无明显相关性(r=0.081,P=0.697)。FS值与超声诊断分组之间具有显著相关性(r=0.685,P=0.000)。结论:FibroScan对诊断HBV感染相关的肝纤维化具有较高的临床价值。 Objective: To explore the clinical application value of FibroScan in the diagnosis of liver fibrosis in patients with hepatitis B virus.Methods: Enrolling randomly 300 patients with hepatitis B virus were detected with FibroScan,including 22 cases of acute hepatitis(AHB),161 cases of chronic hepatitis(CHB) and 171 cases of liver cirrhosis(LC).To analyze the correlations of FibroScan values(FS) and the serum indexes of liver function,HBV DNA loads,serum fibrosis markers and ultrasound diagnosis.Results: FS values were markedly correlated with serum ALB,TBIL,HA,ALT and LN according to multiple linear regression analysis(P〈0.05).The FS value of LC group was significantly higher than that of CHB group and AHB group(P〈0.05),but the different of CHB group and AHB group was no statistical significance(P〉0.05).The FS value was not related to the HBV DNA loads(r=0.081,P=0.697),but correlated with the ultrasonic diagnostic significantly(r=0.685,P=0.000).Conclusion: FibroScan has a better clinical application value in the diagnosis of liver fibrosis in patients with hepatitis B virus.
作者 刘勇鹏 张琳
出处 《中国医药导报》 CAS 2011年第11期42-44,共3页 China Medical Herald
关键词 肝弹性成像系统 肝纤维化 慢性乙型肝炎 乙肝病毒 FibroScan Liver fibrosis Chronic hepatitis Hepatitis B virus
  • 相关文献

参考文献9

  • 1Poynard T, Mathurin P, ~ CL, et al. A comparison of fibrosis progres- sion in chronic liver diseases [J]. J Hepatol,2003,38(3):257-265.
  • 2Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis [J]. Hep- atology,2006,43(2 Suppl 1):S113-120.
  • 3Poynard T, Morra R, Ingiliz P, et al. Assessment of liver fibrosis: non- invasive means [J]. Saudi J Gastroenterol,2008,14(4):163-173.
  • 4病毒性肝炎防治方案[J].传染病信息,2000,13(4):141-150. 被引量:268
  • 5Scott DR, Levy MT. Liver transient elastography (FihroScan): a placein the management algorithms of chronic viral hepatitis [J]. Antivir Ther, 2010,15(1):1-11.
  • 6Alisi A, Pinzani M, Nobili V. Diagnostic power of FibroScan in predict- ingliver fibrosis in nonalcoholic fatty liver disease [J]. Hepatology, 2009,50(6):2048-2049.
  • 7Takemoto R, Nakamuta M, Aoyagi Y, et al. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infec- tion [J]. J Dig Dis,2009,10(2):145-148.
  • 8Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new sur-rogate marker of liver fibrosis influenced by major changes of transami- nases [J]. J Viral Hepat,2007,14(5):360-369.
  • 9Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for pa- tients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis [J]. Hepatology Research, 2007,37(12):1002-1010.

共引文献267

同被引文献184

引证文献17

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部